Richard Toselli - InVivo Therapeutics Chief Medical Officer

Dr. Richard Toselli, M.D., is Principal Accounting Officer, President, Acting Chief Executive Officer and Chief Medical Officer, Director of the Company. He has served as our President and Chief Executive Officer and a director since February 2018. Prior to being appointed President and Chief Executive Officer and a director, Dr. Toselli served as our Acting Chief Executive Officer from December 2017 to February 2018. Since July 2017, Dr. Toselli has also served as our Chief Medical Officer. Before joining the company, Dr. Toselli served as the Chief Medical Officer for Cochlear Limited, a medical device company, from June 2016 until March 2017. Prior to that, Dr. Toselli served at Sanofi, a pharmaceutical company, from July 2012 to June 2016 in various levels of increasing responsibility, including Vice President of Global Medical Affairs Immunology and Inflammation, Biologics Division Vice President of Global Medical Affairs and Head of the Biosurgery Discovery Performance Unit and Vice President of Global Medical Affairs, Biosurgery. Before his time at Sanofi, he served as Chief MedicalTechnology Officer for Covidien Public Limited Company, a medical device company, and earlier held the position of Vice President of EvidenceBased Medicine for the device sector at Johnson Johnson, a medical device, pharmaceutical and consumer packaged goods manufacturing company. Prior to that, Dr. Toselli held various roles at DePuy Synthes Spine, Inc., a medical device company, including Director of Medical Affairs, Worldwide Vice President of Research and Development, and Worldwide Vice President of Clinical Evidence and External Relations. Dr. Toselli holds a bachelor of arts from Providence College, his medical degree from Brown University, and a masters of business administration from the UNCs KenanFlagler Business School. Dr. Toselli is a boardcertified neurological surgeon. since 2018.